Iron-rescue experiments confirm tumor cell mortality is mechanistically driven, not nonspecific cytotoxicity. MIAMI, FL / ...
Creative Biolabs is accelerating CAR‑T innovation, driving breakthroughs in solid tumor targeting. SHIRLEY, NY, UNITED ...
Researchers suggest targeting ECM-mediated regulation of autophagy levels could be used to sensitize pancreatic cancer to FDA-approved therapies.
Explore the OC-PAM AI tool that revolutionizes cancer research with non-invasive imaging of organoids and spheroids.
Iron-rescue experiments confirm tumor cell mortality is mechanistically driven, not nonspecific cytotoxicity. MIAMI, FL / ACCESS Newswire / February 17, 2026 / Telomir Pharmaceuticals, Inc. (NASDAQ:TE ...
In this study, researchers aimed to examine trends in nonsurgical management and other treatment modalities in low-risk, HR-positive DCIS.
Decreases in circulating tumor DNA (ctDNA) within the first month of immune checkpoint inhibitor (ICI) therapy were strongly ...
His project is funded by the ICPO Foundation with 100.000 Euros and was selected from ...
A majority of counties experienced growth in penetration of Medicare value-based approaches: Medicare Shared Savings Program (MSSP) accountable care organizations (ACOs) and Medicare Advantage (MA).
His project is funded by the ICPO Foundation with 100.000 Euros and was selected from 18 high-quality applications from twelve countries February 17, 2026 - Wiesbaden, Germany. The International Cente ...
Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...
Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results